Sanofi Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Sanofi stocks.

Sanofi Stocks Recent News

Date Stock Title
May 10 SNY Fed rates, Tesla Supercharger backpedal, Novavax's 'new chapter': Market Domination
May 10 MACK Merrimack Pharmaceuticals stockholders approve plan of dissolution
May 10 MACK Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock
May 10 SNY Sanofi vaccine deal kicks off Novavax's 'new chapter': Analyst
May 10 SNY Novavax’s 99% Surge Gives ‘Rib-Crunching’ Squeeze to Shorts
May 10 SNY Novavax stock doubles after Sanofi deal marks 'new chapter' for company
May 10 SNY Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with Strategic Partnerships and Cost ...
May 10 SNY Why Novavax Stock More Than Doubled Today
May 10 SNY Top Midday Stories: Biden to Reportedly Quadruple Chinese EV Tariffs; Novavax Shares Soar on Sanofi Deal News; Protesters Try to Break Into Tesla's Plant in Germany; FDA Pushes Back Approval of Moderna Vaccine
May 10 SNY Biotech Rockets 125% On Sanofi Covid Vaccine Agreement
May 10 SNY Novavax-Sanofi vaccine deal, Yelp and Sweetgreen earnings: Morning Brief
May 10 SNY Novavax Stock Price More Than Doubles After COVID-19 Vaccine Licensing Deal With Sanofi
May 10 SNY Novavax Stock More Than Doubles After Sanofi Vaccine-Licensing Deal
May 10 SNY Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
May 10 SNY Update: Novavax Unveils COVID-19 Vaccine Licensing Deal With Sanofi; Shares Soar
May 10 SNY Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases Doubts About Its Going Concern
May 10 SNY Novavax shares skyrocket on $1.2 billion Sanofi vaccine deal
May 10 SNY Novavax Stock Surges 140% on $1.4 Billion Deal With Sanofi
May 10 SNY These Stocks Are Moving the Most Today
May 10 SNY Stock markets, China tariffs, Novavax and Sanofi: 3 Things
Sanofi

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, as of 2013 the world's fifth-largest by prescription sales. The company was formed as Sanofi-Aventis in 2004 by the merger of Aventis and Sanofi-Synthélabo, which were each the product of several previous mergers. It changed its name to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index.Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but the firm also develops over-the-counter medication. The company covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world's largest producer of the latter through its subsidiary Sanofi Pasteur).

Browse All Tags